Vimarsana
Biggest News Aggregation in the World

Page 11 - Tech Acquisition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tech Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tech Acquisition Today - Breaking & Trending Today

Critical Survey: Psychemedics (NASDAQ:PMD) and MedTech Acquisition (NASDAQ:MTAC) - Vimarsana News

Critical Survey: Psychemedics (NASDAQ:PMD) and MedTech Acquisition (NASDAQ:MTAC)

Psychemedics (NASDAQ:PMD – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Institutional and Insider Ownership 24.4% of Psychemedics shares […]

Source: wkrb13.com
Reviewing Castle Biosciences (NASDAQ:CSTL) and MedTech Acquisition (NASDAQ:MTAC) - Vimarsana News

Reviewing Castle Biosciences (NASDAQ:CSTL) and MedTech Acquisition (NASDAQ:MTAC)

MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Profitability This table compares MedTech Acquisition and […]

Source: wkrb13.com
Head to Head Comparison: Sera Prognostics (NASDAQ:SERA) versus MedTech Acquisition (NASDAQ:MTAC) - Vimarsana News

Head to Head Comparison: Sera Prognostics (NASDAQ:SERA) versus MedTech Acquisition (NASDAQ:MTAC)

Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Valuation & Earnings This table compares Sera […]

Source: wkrb13.com
Analyzing Sera Prognostics (NASDAQ:SERA) & MedTech Acquisition (NASDAQ:MTAC) - Vimarsana News

Analyzing Sera Prognostics (NASDAQ:SERA) & MedTech Acquisition (NASDAQ:MTAC)

Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Analyst Ratings This is a summary of […]

CleanTech Acquisition (NASDAQ:CLAQ) Shares Up 0.9% - Vimarsana News

CleanTech Acquisition (NASDAQ:CLAQ) Shares Up 0.9%

CleanTech Acquisition Corp. (NASDAQ:CLAQ – Get Free Report)’s share price shot up 0.9% during mid-day trading on Tuesday . The company traded as high as $2.15 and last traded at $2.15. 20,485 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 54,312 shares. The stock had previously closed […]

Source: wkrb13.com